RIBICHINI, Flavio Luciano
 Distribuzione geografica
Continente #
EU - Europa 13.833
NA - Nord America 12.715
AS - Asia 9.885
SA - Sud America 1.569
AF - Africa 285
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 5
Totale 38.321
Nazione #
US - Stati Uniti d'America 12.460
RU - Federazione Russa 6.556
SG - Singapore 4.341
CN - Cina 2.896
GB - Regno Unito 2.397
BR - Brasile 1.286
HK - Hong Kong 985
DE - Germania 788
FR - Francia 786
IE - Irlanda 700
IT - Italia 693
SE - Svezia 655
VN - Vietnam 648
FI - Finlandia 626
KR - Corea 325
UA - Ucraina 207
CA - Canada 122
IN - India 114
AR - Argentina 99
JP - Giappone 86
MX - Messico 83
ID - Indonesia 73
PL - Polonia 71
TG - Togo 67
TR - Turchia 64
NL - Olanda 63
ZA - Sudafrica 61
BD - Bangladesh 60
EC - Ecuador 49
BE - Belgio 47
ES - Italia 47
AT - Austria 46
BJ - Benin 43
IR - Iran 34
PK - Pakistan 34
CO - Colombia 33
IQ - Iraq 31
MA - Marocco 29
VE - Venezuela 27
EG - Egitto 26
LT - Lituania 22
PY - Paraguay 22
SA - Arabia Saudita 22
AU - Australia 21
UZ - Uzbekistan 21
PE - Perù 19
CZ - Repubblica Ceca 18
RO - Romania 18
AE - Emirati Arabi Uniti 17
CL - Cile 17
IL - Israele 16
JO - Giordania 14
AZ - Azerbaigian 13
OM - Oman 13
KG - Kirghizistan 11
TN - Tunisia 11
BY - Bielorussia 10
CH - Svizzera 10
DZ - Algeria 10
UY - Uruguay 10
PA - Panama 9
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
PT - Portogallo 8
GE - Georgia 7
HU - Ungheria 7
AO - Angola 6
BG - Bulgaria 6
GR - Grecia 6
GT - Guatemala 6
MY - Malesia 6
TH - Thailandia 6
AL - Albania 5
CR - Costa Rica 5
DK - Danimarca 5
LB - Libano 5
NO - Norvegia 5
NP - Nepal 5
PH - Filippine 5
BO - Bolivia 4
CG - Congo 4
LU - Lussemburgo 4
LV - Lettonia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SI - Slovenia 4
TW - Taiwan 4
AM - Armenia 3
EE - Estonia 3
ET - Etiopia 3
GY - Guiana 3
JM - Giamaica 3
KE - Kenya 3
ME - Montenegro 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TJ - Tagikistan 3
TT - Trinidad e Tobago 3
BB - Barbados 2
Totale 38.262
Città #
Moscow 2.179
Singapore 2.043
Southend 2.004
Jacksonville 1.475
Chandler 1.370
Dallas 1.265
Ashburn 1.136
Hong Kong 982
Woodbridge 905
Dublin 688
Ann Arbor 533
Beijing 527
New York 449
Houston 419
The Dalles 340
Los Angeles 278
Princeton 277
Lawrence 276
Munich 253
Wilmington 253
Helsinki 219
Ho Chi Minh City 219
Jinan 211
Nanjing 163
Verona 160
Shenyang 155
Hanoi 136
Redondo Beach 135
Hebei 130
Buffalo 124
São Paulo 114
Tianjin 109
Columbus 100
Seattle 91
Sindelfingen 82
London 77
Santa Clara 77
Changsha 74
Milan 74
Nanchang 70
Lomé 66
Guangzhou 63
Zhengzhou 63
Haikou 62
Seoul 61
Washington 61
Tokyo 59
Turku 57
Warsaw 56
Hangzhou 54
Denver 52
Taizhou 52
Stockholm 51
Boardman 50
Brooklyn 49
Rio de Janeiro 49
Taiyuan 49
Montreal 48
Ningbo 48
Nuremberg 48
Brussels 46
Norwalk 46
Chicago 44
San Francisco 44
Cotonou 43
Fuzhou 43
Jiaxing 43
Johannesburg 41
Frankfurt am Main 40
Atlanta 39
Chennai 38
Redwood City 37
Haiphong 35
Phoenix 33
Poplar 33
Redmond 32
Fairfield 31
Toronto 31
Amsterdam 30
Boston 30
Falkenstein 29
Kent 29
Belo Horizonte 28
Jakarta 28
Rome 28
Lanzhou 27
Brasília 26
Falls Church 25
San Jose 25
Orem 24
Shanghai 24
Bologna 23
Lappeenranta 23
Dong Ket 22
Mexico City 22
Cedar Knolls 21
Da Nang 21
Biên Hòa 20
Curitiba 20
Lancaster 20
Totale 22.514
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 565
Angiography-Derived and Sensor-Wire Methods to Assess Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction 216
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 195
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 190
First successful management of aortic valve insufficiency associated with HeartMate II left ventricular assist device support by transfemoral CoreValve implantation: the Columbus's egg? 188
[The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory]. 184
[Bypass surgery versus percutaneous coronary intervention: evidence, indications and patient preference according to the latest European guidelines on myocardial revascularization] 184
Accuracy of Micro-Computed Tomography in Post-mortem Evaluation of Fetal Congenital Heart Disease. Comparison Between Post-mortem Micro-CT and Conventional Autopsy 182
A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. 178
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 176
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 175
[Analysis of right electrocardiographic leads in 195 normal subjects]. 173
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 173
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. 169
Drug-coated balloon: Long-term outcome from a real world three-center experience 169
[Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct]. 167
A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease: The EXECUTIVE Trial (EXecutive RCT: Evaluating XIENCE V in a Multi Vessel Disease). 167
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 166
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 166
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 166
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. 164
Effects of Aortic Valve Replacement on Left Ventricular Diastolic Function in Patients With Aortic Valve Stenosis 164
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 163
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 162
Hemodynamic predictors of long term survival in end stage cystic fibrosis 160
Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity 160
[Radiologic practice and radioprotection in Italian hemodynamic laboratories]. 159
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 159
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 156
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization 156
Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to and Support for Pulmonary Thromboendarterectomy in Misdiagnosed Chronic Thromboembolic Pulmonary Hypertension 156
[Emergency angioplasty in high-risk acute infarct]. 155
[Primary angioplasty in acute inferior myocardial infarct with anterior ST-segment depression: the long-term follow-up]. 154
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 154
In-stent restenosis. 153
[Elective coronary angioplasty in total absence of heart surgery]. 153
Clinical impact of mitral regurgitation in aortic valve stenosis: Insight from effective regurgitant orifice area 152
[Invasive cardiological diagnosis in an ambulatory regimen of transported inpatients]. 151
Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer 151
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis 151
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 150
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 149
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives 147
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 146
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 146
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 146
[Heart catheterization via the femoral artery with a 4 French and mobilization at 2 hours]. 145
[Technical features of Absorb(TM) BVS implantation in the IT-DISAPPEARS registry] 145
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 145
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 144
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 143
The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention 143
First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm 142
[Diagnostic hemodynamics in day-hospital care]. 141
Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy 141
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 141
Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial 141
Early functional and structural changes of the left atrium in a patient with trastuzumab: related cardiotoxicity 140
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. 140
Optimizing the role of transthoracic echocardiography to improve the cardiovascular risk stratification: the dream of subclinical coronary artery disease detection 139
[Quality assurance and cost control in invasive and interventional cardiology]. 138
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 138
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 138
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 137
Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients 136
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 136
Midventricular Takotsubo cardiomyopathy complicated by a ventricular septal rupture: a surgical management 136
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 135
Elective coronary angioplasty with and without surgical standby: clinical and angiographic criteria for the selection of patients. 135
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 133
Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis 133
On the current epidemic outburst of meta-analytic rage in interventional cardiology. 132
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 132
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 132
Excess mortality associated with progression rate in asymptomatic aortic valve stenosis 132
Angiotensin antagonism in coronary artery disease: results after coronary revascularisation. 131
Concomitant myocardial infarction in identical twins with similar coronary lesions. 131
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). 131
Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study 131
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 131
On-line quantitative coronary analysis in clinical practice: one step closer to reality? 130
Functional mitral regurgitation: are we treating the real target? 130
Impella-protected PCI: the clinical results achieved so far 130
Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial 130
Short communication: staff dose reduction during coronary angiography using low framing speed. 129
Bioresorbable vascular scaffolds in cardiac allograft vasculopathy: a new therapeutic option. 129
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 128
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries 127
Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. 126
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 126
New-onset extreme right axis deviation in acute myocardial infarction: clinical characteristics and outcomes 126
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 126
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 125
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 124
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 124
Role of Speckle Tracking Echocardiography in the Evaluation of Breast Cancer Patients Undergoing Chemotherapy: Review and Meta-analysis of the Literature 123
Early atrial fibrillation detection is associated with higher arrhythmic burden in patients with loop recorder after an embolic stroke of undetermined source 122
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 122
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 121
Early aggressive treatment of unstable angina without on-site cardiac surgical facilities: a prospective study of acute and long-term outcome. 121
Totale 15.153
Categoria #
all - tutte 144.187
article - articoli 144.187
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 288.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021904 0 0 0 0 0 267 28 130 127 62 245 45
2021/20221.722 171 350 15 103 80 47 25 107 67 71 185 501
2022/20234.309 319 454 450 643 351 1.040 91 284 478 22 108 69
2023/20242.862 87 197 277 305 313 595 134 214 23 170 375 172
2024/20257.228 370 414 237 1.182 378 277 353 363 1.186 573 597 1.298
2025/202614.370 1.592 996 1.464 3.633 5.421 1.264 0 0 0 0 0 0
Totale 38.649